Relatlimab
Relatlimab (BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM) . Relatlimab is often used with Nivoluma to treat advanced melanoma.
Product Specifications
CAS Number
1673516-98-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7039277-01 0.02 mg
Recombinant Porcine hemagglutinating encephalomyelitis virus Membrane protein (M)
Ask
View Details 
MBS7039277-02 0.1 mg
Recombinant Porcine hemagglutinating encephalomyelitis virus Membrane protein (M)
Ask
View Details MBS7039277-03 5x 0.1 mg
Recombinant Porcine hemagglutinating encephalomyelitis virus Membrane protein (M)
Ask
View Details 
252124-ML490 100 µL
SSX1 (Synovial Sarcoma, X Breakpoint 1, MGC150425, MGC5162, SSRC) (MaxLight 490)
Ask
View Details